Optimization of the Treatment Algorithm of Patients with Low Resistance to Antiepileptic Drugs Using Pharmacogenetic Tests
loading.default
item.page.date
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Genius Journals
item.page.abstract
The study of pharmacogenetic aspects of pharmacoresident epileptic patients is very little studied in medicine. To study the pharmacokinetics of convulex using therapeutic drug monitoring and pharmacogenetic testing to optimize the treatment of patients with epilepsy